Project Grant R43DK141400
Award Date
6/2/25
Completion Date
5/31/26
Dollars Obligated
$325K
Similar Awards
This federal Project Grant award of $384,923 from the National Institute of Neurological Disorders and Stroke (under CFDA 93.279 - Drug Use and Addiction Research Programs) supports the development of an innovative vaginal dilation device by Lumina Medical LLC. The device is designed to significantly improve pain management for patients with chronic pelvic floor disorders through a girth-adjustable, static-passive stretching mechanism and precise dilation monitoring capabilities. The project...
This $662,832 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports the development and demonstration of a Photoacoustic Visualizer (PAV) system by Actuated Medical, Inc. (doing business as Piezo Resonance Innovations Inc.). The PAV system is intended to improve the accuracy and success rates of sacral nerve stimulation (SNS) lead...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $708,138 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Ann & Robert H Lurie Children's Hospital of Chicago. This 4-year grant, awarded from December 2024 through November 2028, will support the development of a biomechanocompatible small molecule-releasing scaffold for bladder augmentation. The project aims to create an alternative to...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support the development of novel therapeutic approaches to address fecal incontinence and fecal urgency. The $782,916 award to Dignify Therapeutics, LLC will fund research to inhibit sensitized colorectal afferent terminals as a means to prevent or reduce symptoms of fecal incontinence, fecal...
This $337,284 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will support the development of a novel "Precision-Cut Bladder Slice" (PCBS) technology at Boston Children's Hospital. The goal is to enable quantitative assessment of bladder smooth muscle contraction, relaxation, and stiffness in both healthy murine and human tissues, while...
This $345,650 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research by Reshape Lifesciences Inc., a small business joint venture, to develop an innovative "Diabetes Targeted Dual Neuromodulation Therapy (TDN Therapy)." The key objectives are to: Determine the minimum effective current amplitude for the high-frequency...
This $548,830 Project Grant was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which oversees the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant was awarded to Nephsmart LLC, a for-profit limited liability company located in Little Rock, Arkansas, to develop and test a point-of-care device that can predict the future development of severe acute kidney injury (AKI) based on detecting specific protein cleavage...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $704,672 to develop an implantable device to improve vascular access and safety for hemodialysis patients. The device features a 3D-printed titanium shell that guides the hemodialysis needle to the correct insertion point, and a titanium-nitride coated valve that stops bleeding upon...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $238,184 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of Delaware. The grant supports the development of an easy-to-use 3D in vitro model of the developing nephron that can spatially pattern the extracellular matrix, stromal cells, and soluble factors. This microphysiological system aims to enable researchers to investigate the...
The federal Project Grant award R43DK135281 for $687,416 was granted by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports the development of a cutaneous gel formulation for the controlled delivery of a therapeutic to effectively treat diabetic foot ulcers (DFUs). The key products and services to be delivered under this SBIR Phase I award include: 1)...